Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly

NCT00604058 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

236

Enrollment

INDUSTRY

Sponsor class

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: Inactivated Poliomyelitis vaccine (IMOVAX)
BIOLOGICAL: Inactivated Poliomyelitis vaccine (IMOVAX)

Sponsor

Sanofi Pasteur, a Sanofi Company